Specialty Pharma Journal Specialty, Precision & Technology
DUBLIN and CAESAREA, Israel – September 20, 2018 – Medtronic plc (NYSE:MDT), a global leader in medical technology, and Mazor Robotics (NASDAQ:MZOR, TASE:MZOR.TZ), a pioneer in the field of robotic guidance systems, today announced the companies have entered into a definitive merger agreement under which Medtronic will acquire all outstanding ordinary …
Tag Archives: Medtronic
September, 2018
April, 2017
-
18 April
Cardinal Health Buys Three Units from Medtronic for $6.1 Billion
DUBLIN, Ohio, April 18, 2017 /PRNewswire/ — Cardinal Health (NYSE: CAH) today announced that it has entered into a definitive agreement to acquire Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion in cash. The purchase price does not include cash tax benefits of at least $100 …
September, 2016
-
28 September
FDA Approves Medtronic’s Automated Insulin Delivery Device for Type 1 Diabetes
The U.S. Food and Drug Administration today approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes. The human pancreas naturally supplies …
March, 2015
-
24 March
Semma Secures $44 Million and Partners with Novartis for Diabetes Stem Cell Therapy
New diabetes biotech startup, working on a stem cell technology that could potentially reverse the cause of Type 1 diabetes, has picked up $44 million in funding, and entered into a deal with Novartis Pharmaceuticals. Semma Therapeutics announced Tuesday that it has closed a $44 million Series A consisting of …